SRTS — Sensus Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $98.52m
- $83.79m
- $24.41m
- 63
- 57
- 100
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27.3 | 9.58 | 27 | 44.5 | 24.4 |
Cost of Revenue | |||||
Gross Profit | 17.6 | 5.25 | 17 | 29.6 | 14.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 29.2 | 16.5 | 22.9 | 29.7 | 24.8 |
Operating Profit | -1.97 | -6.89 | 4.12 | 14.8 | -0.382 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.7 | -6.84 | 4.12 | 28 | 0.652 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.7 | -6.84 | 4.12 | 24.2 | 0.485 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.7 | -6.84 | 4.12 | 24.2 | 0.485 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.7 | -6.84 | 4.12 | 24.2 | 0.485 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.105 | -0.498 | 0.258 | 0.793 | 0.028 |